Colistin/daptomycin: An unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii

International Journal of Antimicrobial Agents

Volumn 43, Issue 4, 2014, Pages 370-374

  Galani, Irene ^a   Orlandou, Konstantina ^a   Moraitou, Helen ^b   Petrikkos, George ^a   Souli, Maria ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Hospital for Diseases of the Chest 'SOTIRIA'   (Greece)

Author keywords

Lipopeptides; Polymyxins; Synergy

Indexed keywords

COLISTIN; DAPTOMYCIN; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG POTENTIATION; GREECE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; ACINETOBACTER INFECTIONS; DRUG COMBINATION; DRUG EFFECTS; GENETICS; MICROBIAL SENSITIVITY TEST;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; COLISTIN; DAPTOMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ELECTROPHORESIS, GEL, PULSED-FIELD; MICROBIAL SENSITIVITY TESTS;

EID: 84897971355     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.12.010     Document Type: Article

References (16)

1. H.W. Boucher, G.H. Talbot, J.S. Bradley, J.E. Edwards, D. Gilbert, and L.B. Rice et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin Infect Dis 48 2009 1 2
2. Y. Cai, D. Chai, R. Wang, B. Liang, and N. Bai Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies J Antimicrob Chemother 97 2012 1607 1615
3. N.C. Gordon, and D.W. Wareham A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline J Antimicrob Chemother 63 2009 775 780
4. I. Galani, P.D. Rekatsina, D. Hatzaki, D. Plachouras, M. Souli, and H. Giamarellou Evaluation of different laboratory tests for the detection of metallo-β-lactamase production in Enterobacteriaceae J Antimicrob Chemother 61 2008 548 553
5. B.H. Dvorchik, D. Brazier, M.F. DeBruin, and R.D. Arbeit Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects Antimicrob Agents Chemother 47 2003 1318 1323
6. D. Plachouras, M. Karvanen, L.E. Friberg, E. Papadomichelakis, A. Antoniadou, and I. Tsangaris et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria Antimicrob Agents Chemother 53 2009 3430 3436
7. E.J. Giamarellos-Bourboulis, E. Xirouchaki, and H. Giamarellou Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii Diagn Microbiol Infect Dis 40 2001 117 120
8. F. Timurkaynak, F. Can, O.K. Azap, M. Demirbilek, H. Arslan, and S.O. Karaman In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units Int J Antimicrob Agents 27 2006 224 228
9. N.C. Gordon, K. Png, and D.W. Wareham Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii Antimicrob Agents Chemother 54 2010 5316 5322
10. D.W. Wareham, N.C. Gordon, and M. Hornsey In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii J Antimicrob Chemother 66 2011 1047 1051
11. M. Hornsey, and D.W. Wareham In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection Antimicrob Agents Chemother 55 2011 3534 3537
12. M. Hornsey, C. Longshaw, L. Phee, and D.W. Wareham In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens Antimicrob Agents Chemother 56 2012 3080 3085
13. C. Vidaillac, L. Benichou, and R.E. Duval In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates Antimicrob Agents Chemother 56 2012 4856 4861
14. L. Phee, M. Hornsey, and D.W. Wareham In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens Eur J Clin Microbiol Infect Dis 32 2013 1291 1294
15. T.R. Sampson, X. Liu, M.R. Schroeder, C.S. Kraft, E.M. Burd, and D.S. Weiss Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway Antimicrob Agents Chemother 56 2012 5642 5649
16. S. Chopra, M. Torres-Ortiz, L. Hokama, P. Madrid, M. Tanga, and K. Mortelmans et al. Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii J Antimicrob Chemother 65 2010 2598 2601